Skip to contentP
Prestige Consumer Healthcare Inc.
P
PBHPrestige Consumer Healthcare Inc. Q2 2018 · 10-Q
Revenue$258.03M$258.03M+20.0% vs Q2 2017 Net Income$30.71M$30.71M−4.6% vs Q2 2017 EPS Diluted$0.57$0.57−5.0% vs Q2 2017 Gross Profit$144,098,000+16.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Prestige Consumer Healthcare Inc. · CIK 1295947 · Engraved from SEC EDGAR
Operating Cash Flowderived$54,419,000+9.9% Free Cash Flowderived$52,188,000+6.5% Margins · derivedGross margin55.8%−1.8 pt vs Q2 2017
Operating margin29.5%−3.5 pt vs Q2 2017
Net margin11.9%−3.1 pt vs Q2 2017
ended Sep 30, 2017 · filed Nov 2, 2017 · 33 d after period end